News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug
Thursday, September 19, 2024Certara Inc a global leader in modelinformed drug development today shared the results from its collaboration with Ichnos Glenmark Innovation IGI on the firstinhuman dose prediction and selection for ISB IGIs drug candidate is a trispecific Tcell en...
Monument Therapeutics Announces Grant of UK Patent for Neuroinflammation Compound MT1980
Wednesday, September 18, 2024Monument Therapeutics a stratified medicine company developing novel treatments for areas of high unmet need in psychiatry and neurology today announced that the United Kingdom Intellectual Property Office IPO has granted UK patent GB
Thermo Fisher Scientific Announces Expansion of Bioanalytical Laboratory Services in Europe
Wednesday, September 18, 2024The PPD clinical research business of Thermo Fisher Scientific the world leader in serving science announced today the expansion of its global laboratory services with a new bioanalytical lab in GoCo Health Innovation City in Gothenburg Sweden
Ipsen provides update on CONTACT-02 Phase III trial in metastatic castration-resistant prostate cancer following final overall survival analysis
Monday, September 16, 2024Ipsen announced detailed final overall survival OS data from the Phase III CONTACT trial investigating the combination of Cabometyx cabozantinib and atezolizumab in metastatic castrationresistant
AAVantgarde announces first patient dosed in First-In-Human Phase 1/2 LUCE-1 study, evaluating AAVB-081 (Dual-AAV) in retinitis pigmentosa related to Usher Syndrome type 1B
Monday, September 16, 2024AAVantgarde Bio AAVantgarde an Italybased global biotechnology company announced that the first subject has been dosed in the LUCE trial a Phase open label clinical trial to assess safety and tolerability of AAVB
Sanofi, RadioMedix, and Orano Med announce licensing agreement on next-generation radioligand medicine for rare cancers
Friday, September 13, 2024As part of its effort to develop innovative treatments for people living with rare cancers Sanofi has entered into an exclusive licensing agreement with RadioMedix Inc
Turbine Achieves Key Milestone in Collaboration with Ono Pharmaceutical
Friday, September 13, 2024Turbine the biological simulation company using AI to build a digital lab for predictive computational models of human cells and tissue today announced that Ono Pharmaceutical
Roche opens Pharma Research and Development Center in Basel to accelerate scientific innovation
Thursday, September 12, 2024Roche announced the opening of its new Pharma Research and Early Development pRED Center at its global headquarters in Basel Switzerland Equipped with cuttingedge technologies
Actuate Receives FDA Orphan Drug Designation for Elraglusib for Treatment of Soft Tissue Sarcomas
Thursday, September 12, 2024Actuate Therapeutics Inc a clinicalstage biopharmaceutical company focused on developing therapies for the treatment of highimpact difficulttotreat cancers through the inhibition of glycogen synthase kinase beta
Santhera Enters into an Exclusive Distribution Agreement with GENESIS Pharma for AGAMREE® (Vamorolone) in Central and Eastern Europe
Wednesday, September 11, 2024Santhera Pharmaceuticals announces the signing of an exclusive distribution agreement with GENESIS Pharma for AGAMREE vamorolone for the treatment of Duchenne muscular dystrophy DMD in markets in Central and Eastern
